Glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults and
despite recent advances in treatment modalities, GBM remains incurable. Injectable …

In the current study, in order to augment the therapeutic efficacy of curcumin, thermo-
sensitive biodegradable hydrogel composed of poly (ε-caprolactone-co-lactide)-b-poly …

Glioblastoma multiforme (GBM) is the deadliest form of primary brain tumor. GBM tumors are
highly heterogeneous, being composed of tumor cells as well as glioblastoma stem cells …

Glioblastoma (GBM) recurrences are inevitable, and mainly originate from residual tumor
cells and the presence of glioma stem cells (GSC) around the resection cavity borders. We …

Glioblastoma (GBM), characterized by high infiltrative capacity, is the most common and
deadly type of primary brain tumor in adults. GBM cells, including therapy‐resistant …

Intratumoral drug delivery is a promising approach for the treatment of glioblastoma
multiforme (GBM). However, drug washout remains a major challenge in GBM therapy. Our …

Glioblastoma multiforme (GBM) is an aggressive primary brain cancer and although patients
undergo surgery and chemoradiotherapy, residual cancer cells still migrate to healthy brain …

Glioblastoma (GBM) is the deadliest brain tumor for which there is no cure. Bioengineered
GBM models, such as hydrogel-encapsulated spheroids, that capture both cell-cell and cell …

Glioblastoma (GBM) is the most common primary brain tumor and has a poor prognosis; as
such, there is an urgent need to develop innovative new therapies. Tumoricidal stem cells …

In this work, we have reported the preparation and optimization of paclitaxel (PTX) and
temozolomide (TMZ) loaded monomethoxy (polyethylene glycol)-poly (D, L-lactide-co …